UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.617

Sortiert nach

Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike

Bone marrow transplantation (Basingstoke), 2012-01, Vol.47 (1), p.5-14

2012

Volltextzugriff (PDF)

Application of machine learning algorithms for clinical predictive modeling: a data-mining approach in SCT

Bone marrow transplantation (Basingstoke), 2014-03, Vol.49 (3), p.332-337

2014

Volltextzugriff (PDF)

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity

Leukemia, 2006-02, Vol.20 (2), p.322-328

2006

Volltextzugriff (PDF)

How could improved provider communication have improved the care this patient received?

The Journal of family practice, 2018-11, Vol.67 (11), p.708;710;711

2018

Volltextzugriff (PDF)

Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma

Annals of oncology, 2010-01, Vol.21 (1), p.126-132

2010

Volltextzugriff (PDF)

Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced

Leukemia, 2013-04, Vol.27 (4), p.829-835

2013

Volltextzugriff (PDF)

Fludarabine and treosulfan compared with other reduced-intensity conditioning regimens for allogeneic stem cell transplantation in patients with lymphoid malignancies

Bone marrow transplantation (Basingstoke), 2015-12, Vol.50 (12), p.1526-1535

2015

Volltextzugriff (PDF)

G-CSF-primed BM for allogeneic SCT: revisited

Bone marrow transplantation (Basingstoke), 2015-07, Vol.50 (7), p.892-898

2015

Volltextzugriff (PDF)

Allo-SCT for AML and MDS with treosulfan compared with BU-based regimens: reduced toxicity vs reduced intensity

Bone marrow transplantation (Basingstoke), 2012-10, Vol.47 (10), p.1274-1282

2012

Volltextzugriff (PDF)

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-up

Leukemia, 2010-05, Vol.24 (5), p.1050-1052

2010

Volltextzugriff (PDF)

POINT‐OF‐CARE ANTI‐BCMA CAR T‐CELL THERAPY INDUCES ENCOURAGING RESPONSE RATES IN HIGH‐RISK RELAPSED/REFRACTORY MULTIPLE MYELOMA

Hematological oncology, 2023-06, Vol.41 (S2), p.82-83

2023

Volltextzugriff (PDF)

The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Haematologica (Roma), 2015-05, Vol.100 (5), p.683

2015

Volltextzugriff (PDF)

Tunable inkjet printed hybrid carbon nanotubes/nanocrystals light sensor

Sensors and actuators. B, Chemical, 2014-06, Vol.196, p.112-116

2014

Volltextzugriff (PDF)

Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2016-10, Vol.51 (10), p.1313-1317

2016

Volltextzugriff (PDF)

PB1809: CLINICAL TRAJECTORY OF LONG‐TERM SURVIVORS OF ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE INDUCTION CHEMOTHERAPY

HemaSphere, 2022-06, Vol.6 (Suppl), p.1689-1690

2022

Volltextzugriff (PDF)

Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience

Annals of oncology, 2012-10, Vol.23 (10), p.2695-2703

2012

Volltextzugriff (PDF)

Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine busulfan

Leukemia, 2007-10, Vol.21 (10), p.2109-2116

2007

Volltextzugriff (PDF)

Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndrome

Bone marrow transplantation (Basingstoke), 2014-05, Vol.49 (5), p.628-633

2014

Volltextzugriff (PDF)

PATIENTS WITH OUT OF SPECIFICATION TISAGENLECLEUCEL CAN BE SALVAGED WITH A POINT‐OF‐CARE CAR T‐CELLS: AN OBSERVATIONAL INTENTION‐TO‐TREAT SINGLE‐CENTER ANALYSIS

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

IN VITRO ANALYSIS PREDICTS CLINICAL RESPONSE OF B CELL LYMPHATIC MALIGNANCIES TO CD19 CAR‐T CELLS: PHENOTYPIC, TRANSCRIPTIONAL AND FUNCTIONAL STUDY

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma

Leukemia, 2008-06, Vol.22 (6), p.1250-1255

2008

Volltextzugriff (PDF)

Clinical characteristics of Stenotrophomonas maltophilia infection in hematopoietic stem cell transplantation recipients: a single center experience

Infection, 2010-06, Vol.38 (3), p.211-215

2010

Volltextzugriff (PDF)

CT in the clinical and prognostic evaluation of acute graft-vs-host disease of the gastrointestinal tract

British journal of radiology, 2012-08, Vol.85 (1016), p.e416-e423

2012

Volltextzugriff (PDF)

P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT‐OF‐CARE ANTI CD19 CAR T‐CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA

HemaSphere, 2022-06, Vol.6 (Suppl), p.998-999

2022

Volltextzugriff (PDF)

1 – 25 von 1.617

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.353)
Mit Volltextzugriff
(1.472)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(890)
Life Sciences & Biomedicine
(691)
Humans
(433)
Female
(241)
Male
(241)
Biological And Medical Sciences
(232)
Adult
(179)
Middle Aged
(176)
Physical Sciences
(176)
Animals
(166)
Hematology
(155)
Aged
(151)
Medical Sciences
(129)
Chemistry
(117)
Technology
(113)
Oncology
(111)
Fundamental And Applied Biological Sciences. Psychology
(109)
Transplantation
(80)
Stem Cell Transplantation
(77)
Biochemistry & Molecular Biology
(73)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike

Application of machine learning algorithms for clinical predictive modeling: a data-mining approach in SCT

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity

How could improved provider communication have improved the care this patient received?

Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma

Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced

Fludarabine and treosulfan compared with other reduced-intensity conditioning regimens for allogeneic stem cell transplantation in patients with lymphoid malignancies

G-CSF-primed BM for allogeneic SCT: revisited

Allo-SCT for AML and MDS with treosulfan compared with BU-based regimens: reduced toxicity vs reduced intensity

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-up

POINT‐OF‐CARE ANTI‐BCMA CAR T‐CELL THERAPY INDUCES ENCOURAGING RESPONSE RATES IN HIGH‐RISK RELAPSED/REFRACTORY MULTIPLE MYELOMA

The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Tunable inkjet printed hybrid carbon nanotubes/nanocrystals light sensor

Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation

PB1809: CLINICAL TRAJECTORY OF LONG‐TERM SURVIVORS OF ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE INDUCTION CHEMOTHERAPY

Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience

Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndrome

PATIENTS WITH OUT OF SPECIFICATION TISAGENLECLEUCEL CAN BE SALVAGED WITH A POINT‐OF‐CARE CAR T‐CELLS: AN OBSERVATIONAL INTENTION‐TO‐TREAT SINGLE‐CENTER ANALYSIS

IN VITRO ANALYSIS PREDICTS CLINICAL RESPONSE OF B CELL LYMPHATIC MALIGNANCIES TO CD19 CAR‐T CELLS: PHENOTYPIC, TRANSCRIPTIONAL AND FUNCTIONAL STUDY

Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma

Clinical characteristics of Stenotrophomonas maltophilia infection in hematopoietic stem cell transplantation recipients: a single center experience

CT in the clinical and prognostic evaluation of acute graft-vs-host disease of the gastrointestinal tract

P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT‐OF‐CARE ANTI CD19 CAR T‐CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA

Suchergebnisse filtern